J. Severe

发表

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

J. Lieberman, B. Lebowitz, S. Davis, 2005, The New England journal of medicine.

Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment.

Elizabeth B. Owens, H. Kraemer, J. Swanson, 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

3-year follow-up of the NIMH MTA study.

Robert D Gibbons, L Eugene Arnold, Kwan Hur, 2007, Journal of the American Academy of Child and Adolescent Psychiatry.

Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative.

J. Nurnberger, M. Blehar, T. Reich, 1994, Archives of general psychiatry.

Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment – Moderate dose Use Study (LiTMUS) for bipolar disorder

J. Calabrese, A. Nierenberg, M. Thase, 2012, Clinical trials.

Acute treatment response and short term outcome in schizophrenia: first results of the NIMH treatment strategies in schizophrenia study. Treatment Strategies in Schizophrenia Collaborative Study Group.

S. Keith, J. Severe, N. Schooler, 1989, Psychopharmacology bulletin.

Evaluation of learning disorders in children with a psychiatric disorder: An example from the Multimodal Treatment Study for ADHD (MTA Study).

Tom V. Hanley, J. Swanson, W. Pelham, 2000 .

Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study.

A. Gelenberg, J. Levine, M. Mandel, 1980, Advances in biochemical psychopharmacology.

Cost-Effectiveness of Comprehensive, Integrated Care for First Episode Psychosis in the NIMH RAISE Early Treatment Program.

R. Rosenheck, D. Penn, Haiqun Lin, 2016, Schizophrenia bulletin.

Mutations in sphingolipid metabolism genes are associated with ADHD

W. Pelham, R. Gibbons, J. Epstein, 2020, Translational Psychiatry.

The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up.

B. Leventhal, D. Rosenberg, J. Fairbank, 2009, The American journal of psychiatry.

Ensuring data quality in a multicenter clinical trial: remote site data entry, central coordination and feedback.

J. Severe, K. Mueser, J. H. Lee, 1989, Psychopharmacology bulletin.

Multimodal treatment of ADHD in the MTA: an alternative outcome analysis.

H. Kraemer, J. Swanson, W. Pelham, 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.

Norma Pugh, P. Murali Doraiswamy, Madhukar H. Trivedi, 2002, JAMA.

Medication Prescription Practices for the Treatment of First Episode Schizophrenia-Spectrum Disorders: Data from the National RAISE-ETP Study

R. Rosenheck, D. Penn, R. Heinssen, 2015 .

Nine Months of Multicomponent Behavioral Treatment for ADHD and Effectiveness of MTA Fading Procedures

H. Kraemer, J. Swanson, W. Pelham, 2004, Journal of abnormal child psychology.

Emergency/Adjunct services and attrition prevention for randomized clinical trials in children: the MTA manual-based solution.

Cheri J. Shapiro, H. Kraemer, J. Swanson, 2002, Journal of the American Academy of Child and Adolescent Psychiatry.

Socioeconomic status as a moderator of ADHD treatment outcomes.

H. Kraemer, J. Swanson, W. Pelham, 2002, Journal of the American Academy of Child and Adolescent Psychiatry.

Assessing medication effects in the MTA study using neuropsychological outcomes.

Kimberly Hoagwood, L Eugene Arnold, Benedetto Vitiello, 2006, Journal of child psychology and psychiatry, and allied disciplines.

Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects.

J. Swanson, W. Pelham, R. Gibbons, 2007, Journal of the American Academy of Child and Adolescent Psychiatry.

Efficacy of Drug Treatment for Chronic Schizophrenic Patients

J. Severe, N. Schooler, 1984 .

CT morphology and short term outcome in schizophrenia

J. Lieberman, P. Ninan, J. Severe, 1989, Schizophrenia Research.

Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regression

M. Ruggeri, R. Rosenheck, D. Penn, 2018, JAMA psychiatry.

Prevention of relapse in schizophrenia. An evaluation of fluphenazine decanoate.

G. Klerman, J. Levine, J. Severe, 1980, Archives of general psychiatry.

The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.

J. Fairbank, B. Burns, J. Severe, 2007, Archives of general psychiatry.

Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program.

Alexander L. Miller, R. Rosenheck, D. Penn, 2016, The American journal of psychiatry.

Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and Applications for Primary Care Providers

J. Swanson, S. Hinshaw, L. Greenhill, 2001, Journal of developmental and behavioral pediatrics : JDBP.

Development and prediction of postpsychotic depression in neuroleptic-treated schizophrenics.

A. Gelenberg, M. Mandel, M. Mieske, 1982, Archives of general psychiatry.

Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study.

R. Rosenheck, D. Penn, R. Heinssen, 2014, JAMA psychiatry.

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.

Benedetto Vitiello, Barbara Burns, John Curry, 2004, JAMA.

Reliability of the services for children and adolescents-parent interview.

J. Severe, B. Molina, P. Jensen, 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

Anxiety as a Predictor and Outcome Variable in the Multimodal Treatment Study of Children with ADHD (MTA)

J M Swanson, H. Kraemer, J. Swanson, 2000, Journal of abnormal child psychology.

Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium.

J. Calabrese, M. Pencina, A. Nierenberg, 2013, The American journal of psychiatry.

Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial.

H. Kraemer, J. Swanson, S. Hinshaw, 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

Predicting relapse in schizophrenia: Is BDNF a plausible biological marker?

J. Lauriello, D. Goff, J. Bustillo, 2017, Schizophrenia Research.

Longitudinal study of inflammation and relapse in schizophrenia

J. Lauriello, D. Goff, J. Bustillo, 2023, Schizophrenia Research.

Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study.

J. Lauriello, D. Goff, J. Bustillo, 2015, Schizophrenia bulletin.

Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment.

J. Lieberman, S. Keith, I. Glick, 1997, Archives of general psychiatry.

Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment.

J. Lieberman, S. Davis, J. Hsiao, 2006, The American journal of psychiatry.

Peer-Assessed Outcomes in the Multimodal Treatment Study of Children With Attention Deficit Hyperactivity Disorder

H. Kraemer, J. Swanson, W. Bukowski, 2005, Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53.

Diagnostic Interview for Genetic Studies

J. Nurnberger, M. Blehar, T. Reich, 2018 .

Demographic characteristics, treatment history, presenting psychopathology and early course in schizophrenia. Treatment Strategies in Schizophrenia Collaborative Study Group.

P. Ninan, J. Severe, W. Hargreaves, 1989, Psychopharmacology bulletin.

A Randomized Phase II Study of Pemetrexed in Combination With Cisplatin or Carboplatin as First-Line Therapy for Patients With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

H. Kraemer, J. Swanson, W. Pelham, 2013 .

Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic.

J. Lieberman, S. Davis, J. Hsiao, 2006, The American journal of psychiatry.

Treatment for Adolescents With Depression Study (TADS): rationale, design, and methods.

Golda S. Ginsburg, B. Leventhal, G. Koch, 2003, Journal of the American Academy of Child and Adolescent Psychiatry.

Effectiveness of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Patients With Chronic Schizophrenia Following Discontinuation of a Previous Atypical Antipsychotic

J. Lieberman, S. Davis, J. Hsiao, 2006 .

Does multimodal treatment of ADHD decrease other diagnoses?

H. Kraemer, J. Swanson, W. Pelham, 2005, Clinical Neuroscience Research.

Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD.

H. Kraemer, J. Swanson, W. Pelham, 2003, Journal of consulting and clinical psychology.

Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD.

J. Swanson, R. Gibbons, L. Greenhill, 2012, The American journal of psychiatry.

Young adult outcomes in the follow‐up of the multimodal treatment study of attention‐deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression

Elizabeth B. Owens, Tom V. Hanley, Andrea L. Howard, 2017, Journal of child psychology and psychiatry, and allied disciplines.

Which treatment for whom for ADHD? Moderators of treatment response in the MTA.

Elizabeth B. Owens, H. Kraemer, J. Swanson, 2003, Journal of consulting and clinical psychology.

Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: contrasting LiTMUS baseline data with pre-existing placebo controlled trials.

J. Calabrese, A. Nierenberg, M. Thase, 2014, Journal of affective disorders.

Observed Classroom Behavior of Children with ADHD: Relationship to Gender and Comorbidity

H. Kraemer, J. Swanson, W. Pelham, 2002, Journal of abnormal child psychology.

Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses.

Kimberly Hoagwood, Robert D Gibbons, L Eugene Arnold, 2007, Journal of the American Academy of Child and Adolescent Psychiatry.

Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity

Elizabeth B. Owens, Tom V. Hanley, Kimberley D. Lakes, 2017, Journal of child psychology and psychiatry, and allied disciplines.

Elizabeth B. Owens, J. Swanson, W. Pelham, 2006, Journal of consulting and clinical psychology.

Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study.

R. Rosenheck, D. Penn, R. Heinssen, 2015, The American journal of psychiatry.

Response to Commentary on the Multimodal Treatment Study of ADHD (MTA): Mining the Meaning of the MTA

Tom V. Hanley, H. Kraemer, J. Swanson, 2002, Journal of abnormal child psychology.

Parenting and Family Stress Treatment Outcomes in Attention Deficit Hyperactivity Disorder (ADHD): An Empirical Analysis in the MTA Study

J. Swanson, J. Epstein, S. Hinshaw, 2000, Journal of abnormal child psychology.

Depot fluphenazine in the prevention of relapse in schizophrenia: evaluation of a treatment regimen [proceedings].

J. Levine, J. Severe, N. Schooler, 1979, Psychopharmacology bulletin.

Maintenance treatment of schizophrenia: A review of dose reduction and family treatment strategies

S. Keith, J. Severe, N. Schooler, 2005, Psychiatric Quarterly.

Duration of Untreated Psychosis in Community Treatment Settings in the United States.

R. Rosenheck, D. Penn, R. Heinssen, 2015, Psychiatric services.

ADHD comorbidity findings from the MTA study: comparing comorbid subgroups.

H. Kraemer, J. Swanson, W. Pelham, 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices.

H. Kraemer, J. Swanson, W. Pelham, 1997, Archives of general psychiatry.

Symptom profiles in children with ADHD: effects of comorbidity and gender.

J M Swanson, H. Kraemer, J. Swanson, 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

Stabilization and depot neuroleptic dosages.

P. Weiden, J. Severe, S. Schulz, 1993, Psychopharmacology bulletin.

Childhood Factors Affecting Persistence and Desistence of Attention-Deficit/Hyperactivity Disorder Symptoms in Adulthood: Results From the MTA.

Tom V. Hanley, Andrea L. Howard, J. Swanson, 2016, Journal of the American Academy of Child and Adolescent Psychiatry.

Medication treatment strategies in the MTA Study: relevance to clinicians and researchers.

J. Swanson, W. Pelham, S. Hinshaw, 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA.

J. Swanson, S. Hinshaw, L. Greenhill, 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study.

R. Rosenheck, D. Penn, R. Heinssen, 2014, JAMA psychiatry.

What aspects of peer relationships are impaired in children with attention-deficit/hyperactivity disorder?

L Eugene Arnold, Helena C Kraemer, William E Pelham, 2005, Journal of consulting and clinical psychology.

Consistency checks to improve measurement with the Positive and Negative Syndrome Scale (PANSS)

Ariana E. Anderson, L. Opler, J. Rabinowitz, 2017, Schizophrenia Research.

Childhood Predictors of Adult Functional Outcomes in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder (MTA).

Andrea L. Howard, J. Swanson, W. Pelham, 2017, Journal of the American Academy of Child and Adolescent Psychiatry.

Functional Adult Outcomes 16 Years After Childhood Diagnosis of Attention-Deficit/Hyperactivity Disorder: MTA Results.

Elizabeth B. Owens, Kimberley D. Lakes, Andrea L. Howard, 2016, Journal of the American Academy of Child and Adolescent Psychiatry.